Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance

Table 2 Concomitant therapy (n = 949¹)

Category	n	%
All	544	57.3
Pharmacological therapy	520	54.8
Oral antipsychotic drugs	434	45.7
Injectable antipsychotics	12	1.3
Sedative-hypnotics/EPS drugs	112	11.8
Mood stabilizers/antiepileptic drugs	39	4
Antidepressants/anxiolytics	61	6.4
Other categories	105	11.0
Non-pharmacological therapy	156	16.4
ECT	12	1.3
rTMS	14	1.5
Other categories	142	15

¹n = 949, number of patients in the full analysis set with concomitant therapy data documentation.

EPS: Extrapyramidal symptoms; ECT: Electroconvulsive shock therapy; rTMS: Repetitive transcranial magnetic stimulation.